These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 31904426)

  • 1. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of artificial intelligence and machine learning in drug repurposing.
    Ghandikota SK; Jegga AG
    Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeepDRA: Drug repurposing using multi-omics data integration with autoencoders.
    Mohammadzadeh-Vardin T; Ghareyazi A; Gharizadeh A; Abbasi K; Rabiee HR
    PLoS One; 2024; 19(7):e0307649. PubMed ID: 39058696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening-based approaches.
    Ahmed F; Kang IS; Kim KH; Asif A; Rahim CSA; Samantasinghar A; Memon FH; Choi KH
    J Med Virol; 2023 Apr; 95(4):e28693. PubMed ID: 36946499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in drug repurposing using machine learning.
    Urbina F; Puhl AC; Ekins S
    Curr Opin Chem Biol; 2021 Dec; 65():74-84. PubMed ID: 34274565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses.
    López-Cortés A; Cabrera-Andrade A; Echeverría-Garcés G; Echeverría-Espinoza P; Pineda-Albán M; Elsitdie N; Bueno-Miño J; Cruz-Segundo CM; Dorado J; Pazos A; Gonzáles-Díaz H; Pérez-Castillo Y; Tejera E; Munteanu CR
    Sci Rep; 2024 Aug; 14(1):19359. PubMed ID: 39169044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of computational drug repurposing approaches: proposing a novel tensor-matrix-tensor factorization method.
    Zabihian A; Asghari J; Hooshmand M; Gharaghani S
    Mol Divers; 2024 Aug; 28(4):2177-2196. PubMed ID: 38683487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network.
    Yang J; Li Z; Wu WKK; Yu S; Xu Z; Chu Q; Zhang Q
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36347526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
    Lötsch J; Kringel D
    Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing: Iron in the fire for older drugs.
    Sonaye HV; Sheikh RY; Doifode CA
    Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing-an emerging strategy in cancer therapeutics.
    Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Approaches to Drug Repurposing: Methods, Challenges, and Opportunities.
    Cousins HC; Nayar G; Altman RB
    Annu Rev Biomed Data Sci; 2024 Aug; 7(1):15-29. PubMed ID: 38598857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel drug repurposing approach for non-small cell lung cancer using deep learning.
    Li B; Dai C; Wang L; Deng H; Li Y; Guan Z; Ni H
    PLoS One; 2020; 15(6):e0233112. PubMed ID: 32525938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.